Cargando…

Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy

Although immune checkpoint inhibitors (ICIs) have greatly improved cancer treatment, the accuracy of predictive biomarkers for ICI outcomes, such as PD-L1, TMB (tumor mutation burden) or MMR (mismatch repair) deficiency, have not been satisfactory. ARID family members are essential for maintaining t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yan, Yan, Chun, Wang, Xiaofei, Xu, Zhijian, Lv, Jianjian, Xu, Xiaomei, Yu, Wenjun, Zhou, Mi, Yue, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896200/ https://www.ncbi.nlm.nih.gov/pubmed/35239432 http://dx.doi.org/10.1080/15384047.2021.2011643

Ejemplares similares

Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect
por: Han, Xiaying, et al.
Publicado: (2022)

Expression and prognostic values of ARID family members in breast cancer
por: Zhang, Jinfeng, et al.
Publicado: (2021)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes
por: Jiang, Tao, et al.
Publicado: (2020)

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer
por: Zhu, Guangsheng, et al.
Publicado: (2021)

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
por: Fukumoto, Takeshi, et al.
Publicado: (2018)

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2020)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
por: Bai, Rilan, et al.
Publicado: (2020)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)

MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
por: Zhou, Yong, et al.
Publicado: (2022)

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
por: Sun, Ji, et al.
Publicado: (2022)

The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma
por: Li, Siyi, et al.
Publicado: (2022)

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2022)

The pan-cancer landscape of netrin family reveals potential oncogenic biomarkers
por: Hao, Wenjun, et al.
Publicado: (2020)

Roles of sirtuin family members in chronic obstructive pulmonary disease
por: Zhang, Xi-Yue, et al.
Publicado: (2022)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
por: Xu, Ya, et al.
Publicado: (2020)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Prognostic values of the inhibitor of DNA-binding family members in breast cancer
por: Zhou, Xiao-Ling, et al.
Publicado: (2018)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
por: Yang, Zeng, et al.
Publicado: (2022)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

New biomarkers for checkpoint inhibitor therapy
por: Burdett, Nikki, et al.
Publicado: (2020)

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
por: Polano, Maurizio, et al.
Publicado: (2019)

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview
por: Safi, Mohammed, et al.
Publicado: (2023)

Pan‐cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors
por: Jiang, Junjie, et al.
Publicado: (2021)

Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members
por: Zhu, Zemin, et al.
Publicado: (2021)

Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors
por: Chen, Xin‐Yu, et al.
Publicado: (2023)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
por: Chen, Chenxin, et al.
Publicado: (2021)

Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
por: Wang, Jingting, et al.
Publicado: (2022)

Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
por: Wu, Yanmeizhi, et al.
Publicado: (2022)

Expression of TIPE family members in human colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2021)

Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer
por: Zhang, Li-Hua, et al.
Publicado: (2019)

Biomarkers to predict prognosis and response to checkpoint inhibitors
por: Yuasa, Takeshi, et al.
Publicado: (2017)

Biomarkers for predicting the efficacy of immune checkpoint inhibitors
por: Wang, Chengji, et al.
Publicado: (2022)

Biomarkers of therapeutic response with immune checkpoint inhibitors
por: Bindal, Poorva, et al.
Publicado: (2021)

Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade
por: Li, Jingye, et al.
Publicado: (2021)

A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes
por: Iyamu, Iredia D., et al.
Publicado: (2021)

Expression characteristics and their functional role of IGFBP gene family in pan-cancer
por: Liu, Yingnan, et al.
Publicado: (2023)

Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study
por: Shieh, Kevin R., et al.
Publicado: (2021)

DNA-binding properties of ARID family proteins
por: Patsialou, Antonia, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_rv2ehmf9fsk46o4in5ie0831es